Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Digestive Care
Digestive Care
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Pertzye
Pancrelipase
2012-05-17
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pancrelipase
pancreatic neoplasms
,
exocrine pancreatic insufficiency
Aspartame
healthy volunteers/patients
,
colorectal neoplasms
,
chronic renal insufficiency
,
kidney diseases
,
sickle cell anemia
,
knee osteoarthritis
,
osteoarthritis
,
heart failure
,
lung neoplasms
,
ovarian neoplasms
,
sarcoma
,
ovarian epithelial carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
laryngeal neoplasms
,
opioid-related disorders
,
covid-19
,
coronavirus infections
,
carcinoma
,
neoplasms
,
urinary bladder neoplasms
,
brain neoplasms
,
glioma
,
neurofibromatosis 2
,
acoustic neuroma
,
meningioma
,
ependymoma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
neurilemmoma
,
body weight
,
cystic fibrosis
,
melanoma
,
biliary tract neoplasms
,
rare diseases
,
invasive hydatidiform mole
,
non-muscle invasive bladder neoplasms
,
non-hodgkin lymphoma
,
b-cell chronic lymphocytic leukemia
,
mantle-cell lymphoma
,
b-cell lymphoma
,
b-cell leukemia
,
diabetes mellitus
,
chronic obstructive pulmonary disease
,
obesity
,
non-small-cell lung carcinoma
,
asthma
,
pulmonary eosinophilia
,
overweight
,
weight loss
,
hyperkalemia
,
endometrial neoplasms
,
borderline personality disorder
,
personality disorders
,
churg-strauss syndrome
,
eosinophilic granuloma
,
type 2 diabetes mellitus
,
breast neoplasms
,
fibrosis
,
inflammation
,
myocarditis
,
endomyocardial fibrosis
,
postoperative pain
,
depression
,
major depressive disorder
,
depressive disorder
Nadide
healthy volunteers/patients
,
diabetes mellitus
,
covid-19
,
type 1 diabetes mellitus
,
rheumatoid arthritis
,
arthritis
,
pharmacokinetics
,
non-small-cell lung carcinoma
,
head and neck neoplasms
,
coronavirus infections
,
breast neoplasms
,
neoplasms
,
type 2 diabetes mellitus
,
colorectal neoplasms
,
neoplasm metastasis
,
obesity
,
hematologic neoplasms
,
renal cell carcinoma
,
castration-resistant prostatic neoplasms
,
urologic neoplasms
,
pancreatic neoplasms
,
endometrial neoplasms
,
transitional cell carcinoma
,
non-alcoholic fatty liver disease
,
overweight
,
fatty liver
,
weight loss
,
pancreatic ductal carcinoma
,
stomach neoplasms
,
biliary tract neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use